Entos Pharmaceuticals receives $62M Canadian government grant for biomanufacturing facility

The Government of Canada announced a $62 million contribution to support Entos Pharmaceuticals' $198.5 million project to build a 103,000-square-foot biomanufacturing and R&D facility in Edmonton, Alberta. The facility will produce genetic medicines.

“This contribution will help build a 103,000-square-foot facility consisting of a biomanufacturing facility and research and development (R&D) centre.”newswire.ca

• 1 source
• newswire.caCanada supports biomanufacturing capacity to advance next generation medicinesInnovation, Science, Economic Development CanadaMar 11, 2025

Summarized from public sources; check the original articles before acting on it.